SCT and Hepatic steatosis: Furthermore, inhibition of biliary Sct/SR signaling (associated with reduced DR) inhibits hepatic steatosis by down-regulation of the lipid biosynthesis gene elongation of very-long-chain-fatty acids (Elovl1) through increased biliary miRNA-125b coupled with decreased angiogenesis [29].